New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 15, 2014
13:55 EDTPRGOPerrigo weakness creates buying opportunity, says Argus
After Perrigo reported lower than expected Q3 EPS and reduced its guidance, Argus reports that the company's valuation are now in the lower portion of their historical levels. The firm cut its price target on the shares to $160 from $175 but it thinks the company has a number of positive catalysts and keeps a Buy rating.
News For PRGO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
September 29, 2014
07:41 EDTPRGOPerrigo announces out-licensing of preclinical assets to Imago Pharmaceuticals
Subscribe for More Information
07:17 EDTPRGOLumara Health to be acquired in two separate transactions for $1.11B
Subscribe for More Information
07:11 EDTPRGOPerrigo acquires women's health product portfolio from Lumara for $82M
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use